[
    [
        {
            "time": "2021-01-05",
            "orginal_text": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
            "features": {
                "keywords": [
                    "生物类似药",
                    "定价",
                    "价格战",
                    "集采"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "original_text": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
            "scores": {
                "News_content": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-05",
            "orginal_text": "恒瑞医药今日大宗交易成交额超22亿元",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "恒瑞医药今日大宗交易成交额超22亿元",
            "scores": {
                "News_content": "恒瑞医药今日大宗交易成交额超22亿元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-01-05",
            "orginal_text": "北向资金合计净流出44.44亿元，京东方A、东方财富、牧原股份净买入额居前",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流出",
                    "京东方A",
                    "东方财富",
                    "牧原股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "电子",
                    "金融",
                    "农业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "北向资金合计净流出44.44亿元，京东方A、东方财富、牧原股份净买入额居前",
            "scores": {
                "News_content": "北向资金合计净流出44.44亿元，京东方A、东方财富、牧原股份净买入额居前",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-05",
            "orginal_text": "北水爆买30亿中国移动、增持腾讯近18亿；南水再抛海康威视逾25亿",
            "features": {
                "keywords": [
                    "北水",
                    "中国移动",
                    "腾讯",
                    "南水",
                    "海康威视"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "通信",
                    "科技",
                    "安防"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "北水爆买30亿中国移动、增持腾讯近18亿；南水再抛海康威视逾25亿",
            "scores": {
                "News_content": "北水爆买30亿中国移动、增持腾讯近18亿；南水再抛海康威视逾25亿",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-05",
            "orginal_text": "医药生物行业：2021年，医药再启程！",
            "features": {
                "keywords": [
                    "医药生物",
                    "2021",
                    "行业展望"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "original_text": "医药生物行业：2021年，医药再启程！",
            "scores": {
                "News_content": "医药生物行业：2021年，医药再启程！",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-01-05",
            "orginal_text": "医药行业周报：加配弹性品种 稳守核心资产",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "弹性品种",
                    "核心资产"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "original_text": "医药行业周报：加配弹性品种 稳守核心资产",
            "scores": {
                "News_content": "医药行业周报：加配弹性品种 稳守核心资产",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-01-05",
            "orginal_text": "最新中国市值500强重磅出炉 腾讯位居中国市值500强第一 阿里第二",
            "features": {
                "keywords": [
                    "中国市值500强",
                    "腾讯",
                    "阿里"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "最新中国市值500强重磅出炉 腾讯位居中国市值500强第一 阿里第二",
            "scores": {
                "News_content": "最新中国市值500强重磅出炉 腾讯位居中国市值500强第一 阿里第二",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-05",
            "orginal_text": "医药生物行业周观点：国产疫苗获批上市 关注有长逻辑的优质赛道",
            "features": {
                "keywords": [
                    "医药生物",
                    "国产疫苗",
                    "获批上市",
                    "优质赛道"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "original_text": "医药生物行业周观点：国产疫苗获批上市 关注有长逻辑的优质赛道",
            "scores": {
                "News_content": "医药生物行业周观点：国产疫苗获批上市 关注有长逻辑的优质赛道",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]